Integrative Cancer Therapy Fellowship Module III: Immunology of Cancer
Upon completion of the module, the participant will:
Review current concepts in immunology
Know the immunological tests that are currently available
Review the medical literature on immunosuppression and cancer
Look at the multifactorial basis of immunodeficiency in cancer patients
Understand effector cell numbers and function
Know immunoregulatory cells and immunomodulatory factors
Look at immunosuppression and tumor cell burden
Understand the function of T-lymphocytes, T-helper cells, T-suppressor cells, T-cytotoxic cells, B lymphocytes, monocytes, macrophages, natural killer cells, and lymphokine-activated killer cells
Evaluate sold tumors in the light of immunological function
Understand hematopoietic malignancies in the light of immunology
Evaluate radiation-induced immunosuppression
Comprehend chemotherapy-induced immunosuppression
Look at the immune status of patients in clinical remission
Lean treatments of caner-associated immunodeficiency
Know biological response modifiers with immunorestorative properties
Understand the chemical properties of thymic hormones
Learn treatment of radiotherapy-induced immunosuppression
Learn therapies for chemotherapy-induced immunosuppression
Learn about cancer vaccines
Understand the cytokine sources and their effects related to the growth and treatment of cancer
Have a working knowledge of all of the interleukins
Understand tumor necrosis factor alpha and its effects on inflammation, immune regulation, apoptosis, and endothelial damage
Understand interferon therapy for specific cancers
Understand the mode of action of interferons in cancer treatment
Learn about monoclonal antibody therapy
Study immunotoxins
Learn new testing methods for immunological markers
Train in granulocyte colony-stimulating factor therapies
Understand the clinical implications of granulocyte-macrophage colony-stimulating factor therapies and immunomodulation
Review heat shock proteins as regulators of the immune response
Understand the role of gene rearrangement in the tumor response
Look at how tumors avoid the immune response
Schedule:
Low Dose Metronomic Chemotherapy
Mark Rosenberg, MD
1 hr
Organs of the Immune System
Dwight McKee, MD
1 hr
Introduction of Immunology: The Immune System
Dwight McKee, MD
1 hr
Introduction to Tumor Immunology
Dwight McKee, MD
1 hr
Advanced Tumor Immunotherapy
Dwight KcKee, MD
1 hr
ImmunoCompetence/ ImmuneDeficiency and Clinical Course
Donald Braun, PhD
1 hr
Immune Response to Cancer in Different Anatomic Sites
Donald Braun, PhD
1 hr
Cytokine-Based Immune Therapies
Donald Braun, PhD
1 hr
Adoptive Cellular Immunotherapy of Cancer
Donald Braun, PhD
1 hr
Monoclonal Ab Therapy to Cancer
Donald Braun, PhD
1 hr
GcMAF
Dwight KcKee, MD
1 hr
Stress, Immune System and Cancer
Dwight McKee, MD
1 hr
Inflammation, Gut Integrity, Diet and Immune Functions
Dwight McKee, MD
1 hr
Mechanisms of Immune Suppression By Tumor Cells
Dwight McKee, MD
1 hr
Cancer Vaccination Strategies: Clinical Results
Donald Braun, PhD
2 hr
Obesity, Insulin and Cancer: The Role of the Insulin-IGF Pathway on the Origins and the Outcome of Cancer
Barry Boyd, MD
2 hr
Mechanisms for Collaboration Between Conventional Therapy and AntiTumor Immunity
Donald Braun, PhD
1 hr
Effects of Naturopathic/Nutritional Supplements on Immune Response to Cancer
Donald Braun, PhD
1 hr
Integrative Approach to Prostate Cancer
Pyuish Bhatnagar, MD
1 hr
Integrative Approach to Lung Cancer
Pyuish Bhatnagar, MD
1 hr
Epigenetic Regulation of DNA Repair Pathways and Their Modulation to Reverse Chemotherapy Resistance in Melanoma